Sentences with phrase «pharmaceutical discovery research»

He has a Ph.D. from the University of Virginia in biophysics, a B.A. in chemistry and environmental studies from the University of Pennsylvania, and early career experience in pharmaceutical discovery research.

Not exact matches

SOUTH SAN FRANCISCO, Calif. — February 5, 2018 — FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of oral small molecule drugs to activate the immune system against cancer, today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.

Research Triangle Park, NC — August 18, 2015 — Phoundry Pharmaceuticals, Inc., an RTP, North Carolina — based company focusing on the discovery of peptide therapeutics, announced today that it has successfully completed its first seed financing, putting it in position to advance its discovery and partnering plans.

With neurological disorders affecting approximately one - third of the U.S. population, and pharmaceutical firms largely abandoning their R&D efforts in neuroscience, the work of academic research institutions such as CSHL is crucial in the effort to drive innovation and discovery in this field.»

As neurological disorders affect approximately one - third of the U.S. population, and pharmaceutical firms are largely abandoning their research and development efforts in neuroscience, the work of academic research institutions is crucial in the effort to drive innovation and discovery in this field.

Although the pharmaceutical industry, like the rest of the business world, has suffered a slowdown, the market research company Frost and Sullivan still expects spending on drug discovery to expand from US$ 19.6 billion in 2002 to US$ 25.6 billion by 2006, an annual growth rate of about 6 %.

Making the Leap: When, How, and Why a Career in Drug Discovery May Be Right for You Matthew Bell who heads of discovery research for Wyeth Pharmaceuticals tells when, how, and why a career in drug discovery may be right for you.

So, I took a job as a research scientist in the analytical lab of a smaller chemistry - driven, discovery - based pharmaceutical company located in Vancouver, B.C. With fewer than 100 employees and no products on the market, it couldn't have been further from the formal corporate work environment I was accustomed to at a multinational company.

«The perception of Wyeth as a strong science - driven pharmaceutical company is gaining ground and is a genuine transformation,» says Frank Walsh, vice president and head of discovery research.

Lowe, a medical chemist by profession, provides daily commentary on drug discoveries, the pharmaceutical industry, and relevant research and news, especially in chemistry.

The Canadian drug discovery industry is still small, especially in comparison to the United States, owing to the lack of big pharmaceutical companies conducting research and development in this country.

A scientist from the NIH was one author of the paper describing the discovery, but Myriad Pharmaceuticals, which signed an exclusive licence with the University of Utah where the rest of the research was done, doesn't seem interested in sharing the profits if a breast cancer screening test is devised based on the discovery.

«This opens up entirely new opportunities in pharmaceutical research and may lead to the discovery of new drugs,» says Yitzhak Apeloig, who specializes in organic chemistry at the Technion Israel Institute of Technology in Haifa.

Deuterium - and tritium - labeled pharmaceutical compounds are pivotal diagnostic tools in drug discovery research, providing vital information about the biological fate of drugs and drug metabolites.

Its hard - hitting intellectual property adjunct — the Wisconsin Alumni Research Foundation (WARF)-- appears to have clobbered a biotech partner, Xenon Pharmaceuticals Inc. of Burnaby, Canada, that it says tried to exploit a discovery from Wisconsin's biochem labs without paying the university some disputed fees.

The pharmaceutical industry is research and development driven, given that company growth and viability are dependent on the discovery of new drug molecules.

Overall, the upcoming involvement of academia in the drug discovery process will provide graduate students and postdocs the opportunity to gain experience and skills which are important for pharmaceutical and biotech companies whilst still engaging in hypothesis - driven academic research.

This is the barren territory that few traverse successfully, as many research institutions fail to move a promising biomedical discovery through all the rigorous tests required before a drug company wants to transform the discovery into a pharmaceutical product to help patients.

To help Gladstone discoveries successfully cross through the valley of death, the Hellman Family Foundation Alzheimer's Research Program subsidizes the myriad of early - stage, de-risking tests necessary to make a drug candidate more attractive to pharmaceutical - industry partners, such as tests that reveal at what concentrations a drug stops being therapeutic and instead becomes toxic.

He has more than 25 years of experience in pharmaceutical research with a track record in discovery of first - in - class clinical candidates.

He also held several positions of increasing leadership at Praecis Pharmaceuticals, including Director of Cell Biology, where he initiated or contributed to the establishment of numerous research projects focusing on the discovery of novel therapeutics for the treatment of cancer, inflammation, infectious disease, and neurological disorders.

It's a discovery that could have promising implications for fields as varied as biofuel production, solar energy, opto - electronic devices, pharmaceuticals and medical research.

Jörg has a proven ability of managing small companies, directing preclinical drug research and discovery, external collaborations and working in multinational environments in the biotech and pharmaceutical industry.

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing range of products and services — in gene discovery, pharmaceuticals, DNA - based diagnostics, pharmacogenomics, in silico discovery tools, bioinformatics and medical decision support systems.

In a separate effort, Partners HealthCare, founded by Brigham and Women's Hospital and MGH, launched Partners Innovation in 2008 to improve the bridge between basic and translational research groups and businesses, thereby accelerating laboratory discoveries and making them more accessible to pharmaceutical companies, device manufacturers and venture capitalists.

With its uniquely comprehensive population data, deCODE is turning research on the genetic causes of common diseases into a growing pipeline of products and services — in pharmaceuticals, gene and drug discovery, DNA - based diagnostics, pharmacogenomics, bioinformatics, and clinical trials.

One result of the team's painstaking research was the discovery of how a specific protein influences neutrophil activation — and, more importantly, the team showed they were able to block damaging inflammation by over-compensating neutrophils with a pharmaceutical compound.

Research, review and revise discovery requests and responses for several complex pharmaceutical litigation matters in federal court.

Dedicated, self - motivated research scientist with over 15 years drug discovery experience seeking a challenging opportunity in biotech - pharmaceutical industry where I can enhance and utilize my technical expertise to contribute to new drug development and server the patients.